Vaxxel

Vaxxel is a preclinical-stage biotechnology company dedicated to developing innovative live-attenuated vaccines to combat respiratory infections, particularly those caused by pneumoviruses such as human Metapneumovirus (hMPV) and Respiratory Syncytial Virus (RSV). The company focuses on creating intranasal vaccine candidates to prevent bronchiolitis and viral pneumonia.